BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33792981)

  • 1. Next generation sequencing in cytology.
    Pisapia P; Pepe F; Sgariglia R; Nacchio M; Russo G; Conticelli F; Girolami I; Eccher A; Bellevicine C; Vigliar E; Malapelle U; Troncone G
    Cytopathology; 2021 Sep; 32(5):588-595. PubMed ID: 33792981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of cytology smears improves success rates of RNA-based next-generation sequencing gene fusion assays for clinically relevant predictive biomarkers.
    Ramani NS; Chen H; Broaddus RR; Lazar AJ; Luthra R; Medeiros LJ; Patel KP; Rashid A; Routbort MJ; Stewart J; Tang Z; Bassett R; Manekia J; Barkoh BA; Dang H; Roy-Chowdhuri S
    Cancer Cytopathol; 2021 May; 129(5):374-382. PubMed ID: 33119213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting the success of next-generation sequencing in cytology specimens.
    Roy-Chowdhuri S; Goswami RS; Chen H; Patel KP; Routbort MJ; Singh RR; Broaddus RR; Barkoh BA; Manekia J; Yao H; Medeiros LJ; Staerkel G; Luthra R; Stewart J
    Cancer Cytopathol; 2015 Nov; 123(11):659-68. PubMed ID: 26230354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Big data from small samples: Informatics of next-generation sequencing in cytopathology.
    Roy-Chowdhuri S; Roy S; Monaco SE; Routbort MJ; Pantanowitz L
    Cancer Cytopathol; 2017 Apr; 125(4):236-244. PubMed ID: 27918649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges and opportunities of next-generation sequencing: a cytopathologist's perspective.
    Vigliar E; Malapelle U; de Luca C; Bellevicine C; Troncone G
    Cytopathology; 2015 Oct; 26(5):271-83. PubMed ID: 26399861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted RNA sequencing with touch imprint cytology samples for non-small cell lung cancer patients.
    Seto K; Masago K; Fujita S; Haneda M; Horio Y; Hida T; Kuroda H; Hosoda W; Okubo KI
    Thorac Cancer; 2020 Jul; 11(7):1827-1834. PubMed ID: 32372482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-Generation Sequencing and Fluorescence in Situ Hybridization Have Comparable Performance Characteristics in the Analysis of Pancreaticobiliary Brushings for Malignancy.
    Dudley JC; Zheng Z; McDonald T; Le LP; Dias-Santagata D; Borger D; Batten J; Vernovsky K; Sweeney B; Arpin RN; Brugge WR; Forcione DG; Pitman MB; Iafrate AJ
    J Mol Diagn; 2016 Jan; 18(1):124-30. PubMed ID: 26596524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tiny but mighty: use of next generation sequencing on discarded cytocentrifuged bile duct brushing specimens to increase sensitivity of cytological diagnosis.
    Harbhajanka A; Michael CW; Janaki N; Gokozan HN; Wasman J; Bomeisl P; Yoest J; Sadri N
    Mod Pathol; 2020 Oct; 33(10):2019-2025. PubMed ID: 32457409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invited review-next-generation sequencing: a modern tool in cytopathology.
    Roy-Chowdhuri S; Pisapia P; Salto-Tellez M; Savic S; Nacchio M; de Biase D; Tallini G; Troncone G; Schmitt F
    Virchows Arch; 2019 Jul; 475(1):3-11. PubMed ID: 30877381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of Molecular Testing of Cytology Specimens.
    Huang M; Wei S
    Acta Cytol; 2020; 64(1-2):136-146. PubMed ID: 30917368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of targeted next-generation sequencing in patients with suspected pancreatic or periampullary cancer.
    Sibinga Mulder BG; Mieog JSD; Farina Sarasqueta A; Handgraaf HJ; Vasen HFA; Swijnenburg RJ; Luelmo SAC; Feshtali S; Inderson A; Vahrmeijer AL; Bonsing BA; Wezel TV; Morreau H
    J Clin Pathol; 2018 Mar; 71(3):246-252. PubMed ID: 28775172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of cytological material, pre-analytical procedures and bio-banking in effusion cytopathology.
    Engels M; Michael C; Dobra K; Hjerpe A; Fassina A; Firat P
    Cytopathology; 2019 Jan; 30(1):31-38. PubMed ID: 30430668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Ancillary Techniques in Biliary Cytopathology Specimens.
    Layfield L
    Acta Cytol; 2020; 64(1-2):175-181. PubMed ID: 31121596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using "residual" FNA rinse and body fluid specimens for next-generation sequencing: An institutional experience.
    Wei S; Lieberman D; Morrissette JJ; Baloch ZW; Roth DB; McGrath C
    Cancer Cytopathol; 2016 May; 124(5):324-9. PubMed ID: 26682952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive validation of liquid-based cytology specimens for next-generation sequencing in cancer genome analysis.
    Akahane T; Yamaguchi T; Kato Y; Yokoyama S; Hamada T; Nishida Y; Higashi M; Nishihara H; Suzuki S; Ueno S; Tanimoto A
    PLoS One; 2019; 14(6):e0217724. PubMed ID: 31199826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.
    Velizheva NP; Rechsteiner MP; Wong CE; Zhong Q; Rössle M; Bode B; Moch H; Soltermann A; Wild PJ; Tischler V
    Cancer Cytopathol; 2017 Jan; 125(1):30-40. PubMed ID: 27636102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.
    Treece AL; Montgomery ND; Patel NM; Civalier CJ; Dodd LG; Gulley ML; Booker JK; Weck KE
    Cancer Cytopathol; 2016 Jun; 124(6):406-14. PubMed ID: 26882436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples?
    Bellevicine C; Sgariglia R; Malapelle U; Vigliar E; Nacchio M; Ciancia G; Eszlinger M; Paschke R; Troncone G
    Cancer Cytopathol; 2016 Nov; 124(11):776-784. PubMed ID: 27717198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted deep sequencing of effusion cytology samples is feasible, informs spatiotemporal tumor evolution, and has clinical and diagnostic utility.
    Leichsenring J; Volckmar AL; Kirchner M; Kazdal D; Kriegsmann M; Stögbauer F; Bockmayr T; Klauschen F; Herth FJF; Penzel R; Warth A; Schirmacher P; Endris V; Stenzinger A
    Genes Chromosomes Cancer; 2018 Feb; 57(2):70-79. PubMed ID: 29044880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-Generation Sequencing Identifies Gene Mutations That Are Predictive of Malignancy in Residual Needle Rinses Collected From Fine-Needle Aspirations of Thyroid Nodules.
    Fuller MY; Mody D; Hull A; Pepper K; Hendrickson H; Olsen R
    Arch Pathol Lab Med; 2018 Feb; 142(2):178-183. PubMed ID: 28537807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.